Skip to main content

FDA purchases YMC technology

FDA specifies bench top technology for study on continuous chromatography.

Learn more.

Posted on July 14, 2020.

Related Posts

June 2, 2026

Chromatography of Biotherapeuticals – Analyzing and Purifying Peptides and Oligonucleotides

This webinar will highlight how advanced ultra-high-performance liquid chromatography (UHPLC) strategies, carefully selected stationary phases, and bioinert hardware can significantly improve the analysis and purification of peptides and oligonucleotides.

May 21, 2026

Breaking Down mRNA Capping Efficiency with High-Resolution IP-RP LC

Evaluating 5' capping efficiency is a critical quality attribute in therapeutic mRNA manufacturing, directly impacting translation efficiency and transcript stability. However, separating structurally similar capped, partially capped, and uncapped species differing by just a single nucleotide remains a significant chromatographic challenge.

May 7, 2026

Revolutionizing CRISPR Applications: High-Resolution sgRNA Analysis

Ensuring the quality of single guide RNA (sgRNA) is a major hurdle in CRISPR-Cas genome editing. Because these molecules are large (~100mer) and prone to complex secondary structures, separating them from nearly identical impurities requires precision. Our latest application note

Designed and developed by